Last $0.10 HKD
Change Today -0.002 / -1.90%
Volume 5.6M
8225 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 11:05 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

venturepharm laboratories (8225) Snapshot

Open
$0.11
Previous Close
$0.11
Day High
$0.11
Day Low
$0.10
52 Week High
03/3/14 - $0.53
52 Week Low
12/22/14 - $0.09
Market Cap
94.3M
Average Volume 10 Days
3.7M
EPS TTM
$-0.08
Shares Outstanding
915.3M
EX-Date
04/7/04
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VENTUREPHARM LABORATORIES (8225)

Related News

No related news articles were found.

venturepharm laboratories (8225) Related Businessweek News

No Related Businessweek News Found

venturepharm laboratories (8225) Details

Venturepharm Laboratories Limited, an investment holding company, provides drug discovery and development services in the People’s Republic of China and internationally. Its drug discovery and development services include formulation development, clinical trials, product registration, marketing, and sales. The company engages in the research, development, and production of new drug preparation, raw materials, supplementary materials, biodrugs, natural drugs, and synthetic drugs, as well as technology transfer services; manufacture and sale of active pharmaceutical ingredients products; and pharmacodynamic and clinical research of drugs. It also offers pre-clinical research services, such as pharmacology, toxicology, and pharmacokinetics studies; clinical research services, including phase I-IIa clinical and bioequivalence studies, phase II-IV clinical research, bio equivalence research, in-vivo analysis research services, phase IV post-marketing clinical services, data management, medical statistics, medical administration related services, etc.; and regulatory affair and strategy consultation services. The company provides its products and services in various therapeutic areas, such as endocrinology, central nervous system, cardiovascular, gastrointestinal, infection, oncology, allergy, hepatitis, vaccine, hematology, diabetes, immunology, and respiratory. It primarily serves pharmaceutical companies, pharmaceutical distributors, and patients. The company has strategic alliances primarily with various hospitals. Venturepharm Laboratories Limited was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Founded in 1998

venturepharm laboratories (8225) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: CNY81.0K
Head of Human Resources Management Department...
Total Annual Compensation: CNY158.0K
Compensation as of Fiscal Year 2013.

venturepharm laboratories (8225) Key Developments

Venturepharm Laboratories Ltd., Board Meeting, Dec 16, 2014

Venturepharm Laboratories Ltd., Board Meeting, Dec 16, 2014., at 10:00 China Standard Time. Agenda: To discuss and review various fund raising alternatives in the first quarter of 2015 for the purpose of repayingpart of the overdue debts of approximately RMB 30,000,000 owed by the company's subsidiaries in China, including but not limited to possible further round of placing, open offer, rights issue and/or issue of convertible notes; and to discuss any other business, if necessary.

Venturepharm Laboratories Ltd. Reports Consolidated Earnings Results for the Year Ended December 31, 2013

Venturepharm Laboratories Ltd. reported consolidated earnings results for the year ended December 31, 2013. For the period, the company reported revenue of RMB 14,931,000 compared to RMB 28,688,000 a year ago. Loss before income tax was RMB 30,966,000 compared to profit before income tax of RMB 3,231,000 a year ago. Total comprehensive loss attributable to owners of the company was RMB 31,028,000 compared to total comprehensive income attributable to owners of the company of RMB 3,207,000 a year ago. Basic and diluted loss per share was 8.50 cents compared to 0.88 cents a year ago. Net cash used in operating activities was RMB 1,779,000 compared to RMB 6,617,000 a year ago. Purchase of property, plant and equipment was RMB 1,000 compared to RMB 809,000 a year ago.

Venturepharm Laboratories Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Venturepharm Laboratories Ltd. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, turnover was RMB 2.4 million against RMB 1.3 million last year. Loss from operations was RMB 3.1 million against RMB 1.6 million last year. Loss before taxation was RMB 4.5 million against RMB 2.8 million last year. Loss attributable to equity holders of the company was RMB 4.5 million against RMB 2.8 million last year. Diluted loss per share was 0.79 cents against 0.82 cents last year. For the nine months, turnover was RMB 6.6 million against RMB 12.6 million last year. Loss from operations was RMB 5.5 million against RMB 4.8 million last year. Loss before taxation was RMB 8.0 million against RMB 7 million last year. Loss attributable to equity holders of the company was RMB 8 million against RMB 7 million last year. Diluted loss per share was 1.08 cents against 1.33 cents last year. Due to the revenue decrease, the group suffered a loss from operations. As there was a significant change in the Chinese Government's policies and regulations in drug approval, especially the newly released GMP regulation (revised in 2010 and effective in 2011), which led to the increase in rigidity and cautiously in government approval and increased the timing and risk in new drug development, the total revenue dropped significantly.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8225:HK $0.10 HKD -0.002

8225 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8225.
View Industry Companies
 

Industry Analysis

8225

Industry Average

Valuation 8225 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENTUREPHARM LABORATORIES, please visit www.venturepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.